Elevation Oncology Shares Outstanding vs. Price To Book
| ELEV Stock | USD 0.61 0.01 1.67% |
For Elevation Oncology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Elevation Oncology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Elevation Oncology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Elevation Oncology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Elevation Oncology over time as well as its relative position and ranking within its peers.
Elevation |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevation Oncology. If investors know Elevation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevation Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.25) | Return On Equity (0.64) |
The market value of Elevation Oncology is measured differently than its book value, which is the value of Elevation that is recorded on the company's balance sheet. Investors also form their own opinion of Elevation Oncology's value that differs from its market value or its book value, called intrinsic value, which is Elevation Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevation Oncology's market value can be influenced by many factors that don't directly affect Elevation Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevation Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevation Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevation Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Elevation Oncology Price To Book vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Elevation Oncology's current stock value. Our valuation model uses many indicators to compare Elevation Oncology value to that of its competitors to determine the firm's financial worth. Elevation Oncology is rated # 2 in shares outstanding category among its peers. It is rated below average in price to book category among its peers . The ratio of Shares Outstanding to Price To Book for Elevation Oncology is about 114,950,612 . Price To Book Ratio is likely to climb to 0.35 in 2024. Comparative valuation analysis is a catch-all technique that is used if you cannot value Elevation Oncology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Elevation Price To Book vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Elevation Oncology |
| = | 59.12 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Elevation Oncology |
| = | 0.51 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Elevation Price To Book Comparison
Elevation Oncology is currently under evaluation in price to book category among its peers.
Elevation Oncology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Elevation Oncology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Elevation Oncology will eventually generate negative long term returns. The profitability progress is the general direction of Elevation Oncology's change in net profit over the period of time. It can combine multiple indicators of Elevation Oncology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 9 K | 9.4 K | |
| Operating Income | -45.4 M | -47.7 M | |
| Income Before Tax | -45.7 M | -48 M | |
| Total Other Income Expense Net | -229 K | -240.4 K | |
| Net Loss | -85.6 M | -81.3 M | |
| Net Loss | -45.7 M | -48 M | |
| Income Tax Expense | 30 K | 31.5 K | |
| Net Loss | -56.8 M | -59.7 M | |
| Net Interest Income | -300 K | -315 K | |
| Interest Income | 3.9 M | 2.7 M | |
| Non Operating Income Net Other | -455.4 K | -478.2 K | |
| Change To Netincome | 4 M | 4.2 M | |
| Net Loss | (1.34) | (1.41) | |
| Income Quality | 1.23 | 0.75 | |
| Net Income Per E B T | 1.00 | 0.80 |
Elevation Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Elevation Oncology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Elevation Oncology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Elevation Oncology's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Elevation Oncology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Use Investing Themes to Complement your Elevation Oncology position
In addition to having Elevation Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.